Evidence map›Paper›PMID 41931390›Full record

ArticleCell reports2026

Host microRNA-31-5p regulates KHDRBS3 expression and modulates viral gene expression during KSHV lytic reactivation.

Soo Mi Lee, Christopher L Avalos, Christos Miliotis, Hanna M Doh, Erica Chan, Kenneth M Kaye, Frank J Slack

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soo Mi LeeDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA 02115, USA; Program in Virology, Division of Medical Sciences, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.
Christopher L AvalosDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
Christos MiliotisDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA 02115, USA.
Hanna M DohDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
Erica ChanDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
Kenneth M KayeProgram in Virology, Division of Medical Sciences, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Frank J SlackDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: fslack@bidmc.harvard.edu.

Funding

Precision microRNA medicine in cancerR35CA232105 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SLACK, FRANK J. · 2019 to 2025
$7.2M
KSHV Latent Infection ReplicationR01DE025208 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 2015 to 2025
$5.3M
KSHV Latency RegulationR01AI165382 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Kenneth M Kaye · 2022 to 2026
$3.5M
Genetic and Biochemical Studies of KSHV LANAR01AI150575 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KAYE, KENNETH M · 2020 to 2024
$3.4M
NCI NIH HHS R35 CA232105NIAID NIH HHS R01 AI150575NIAID NIH HHS R01 AI165382NIDCR NIH HHS R01 DE025208
6 · The paper itself

Abstract

Oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) employs a biphasic life cycle consisting of latency and lytic replication to achieve lifelong infection. Despite its essential role in KSHV persistence and tumorigenicity, much remains unknown about how KSHV lytic reactivation is regulated. Leveraging high-throughput transcriptomics, we identify microRNA-31-5p (miRNA-31-5p) as a key regulator of KSHV lytic reactivation, capable of modulating expression of KSHV lytic genes and progression through the lytic cascade. Mechanistically, miR-31-5p controls the KSHV lytic switch by regulating expression of the RNA-binding protein KHDRBS3. miR-31-5p-mediated KHDRBS3 repression results in decreased nascent transcription of crucial viral lytic genes including the main KSHV transcription factor RTA. We characterize KHDRBS3 as a major host factor that is critical for KSHV lytic replication and uncover its key role in KSHV lytic gene transcription. Our results highlight a pivotal role for the miR-31-5p/KHDRBS3 axis in modulating KSHV reactivation and provide insights into gene-expression regulation of lytic KSHV.

Indexed as

CP: microbiologyCP: molecular biologyKHDRBS3KSHVlytic reactivationmiR-31-5pSLM2transcription

Identifiers

PMID41931390
PMCPMC13222652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.